FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894883173> ?p ?o ?g. }

• W2894883173 endingPage "3060" @default.
• W2894883173 startingPage "3060" @default.
• W2894883173 abstract "Cisplatin is one of the most potent chemotherapy drugs widely used for cancer treatment. However, due to resistance and toxicity, the application of cisplatin for the treatment of hepatocellular carcinoma (HCC) is limited. Our previous study has shown that granulin A (GRN A), an anticancer peptide, is able to interact with enolase1 (ENO1) and inhibit the growth of HCC in vitro. In the present study, we studied the synergistic effect of the combination of cisplatin and GRN A for the inhibitory effect on HCC. An 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay and Chou-Talalay approaches revealed that the combination of GRN A and cisplatin displayed potent synergistic effect. The colony formation and cell viability of HCC cells were inhibited significantly in cells treated with the combination of cisplatin and GRN A, compared with cells treated with cisplatin or GRN A alone. Overexpression of ENO1 diminished the synergistic effect of GRN A and cisplatin in HCC cells. The combination of the two drugs exhibited a more obvious inhibitory effect on cancer cell apoptosis, as analyzed by the cytometry flow, mitochondrial membrane potential (MMP) and western blot analysis. An in vivo study confirmed that the combined use of the two drugs displayed more potent antitumor activity compared to mice treated with cisplatin and GRN A alone; the inhibitory rate of tumor growth was 65.46% and 68.94%, respectively, in mice treated with GRN A and cisplatin. However, the inhibitory rate increased to 86.63% in mice treated with the combination of the two drugs. This study provides evidence that the combination of GRN A and cisplatin is able to sensitize the liver cancer to cisplatin, and that targeting ENO1 is a promising approach for enhancing the antitumor activity of cisplatin." @default.
• W2894883173 created "2018-10-12" @default.
• W2894883173 creator A5001914805 @default.
• W2894883173 creator A5003856071 @default.
• W2894883173 creator A5019056174 @default.
• W2894883173 creator A5024471265 @default.
• W2894883173 creator A5033443384 @default.
• W2894883173 creator A5035358476 @default.
• W2894883173 creator A5063127682 @default.
• W2894883173 creator A5073515685 @default.
• W2894883173 creator A5074822731 @default.
• W2894883173 creator A5081957059 @default.
• W2894883173 date "2018-10-07" @default.
• W2894883173 modified "2023-09-29" @default.
• W2894883173 title "Granulin A Synergizes with Cisplatin to Inhibit the Growth of Human Hepatocellular Carcinoma" @default.
• W2894883173 cites W1503438909 @default.
• W2894883173 cites W1559233041 @default.
• W2894883173 cites W1790542583 @default.
• W2894883173 cites W1985967806 @default.
• W2894883173 cites W1986029990 @default.
• W2894883173 cites W1987604182 @default.
• W2894883173 cites W2009669046 @default.
• W2894883173 cites W2013270589 @default.
• W2894883173 cites W2042642849 @default.
• W2894883173 cites W2044940518 @default.
• W2894883173 cites W2069604352 @default.
• W2894883173 cites W2071506198 @default.
• W2894883173 cites W2083416941 @default.
• W2894883173 cites W2092197187 @default.
• W2894883173 cites W2092595468 @default.
• W2894883173 cites W2101031676 @default.
• W2894883173 cites W2104153516 @default.
• W2894883173 cites W2121545342 @default.
• W2894883173 cites W2136197422 @default.
• W2894883173 cites W2151305493 @default.
• W2894883173 cites W2167219679 @default.
• W2894883173 cites W2167599107 @default.
• W2894883173 cites W2169017799 @default.
• W2894883173 cites W2233986363 @default.
• W2894883173 cites W2272984102 @default.
• W2894883173 cites W2278841906 @default.
• W2894883173 cites W2341763698 @default.
• W2894883173 cites W2344347088 @default.
• W2894883173 cites W2529904548 @default.
• W2894883173 cites W2530003115 @default.
• W2894883173 cites W2539981170 @default.
• W2894883173 cites W2589420311 @default.
• W2894883173 cites W2597173714 @default.
• W2894883173 cites W2603358613 @default.
• W2894883173 cites W2604619953 @default.
• W2894883173 cites W2617314594 @default.
• W2894883173 cites W2618584271 @default.
• W2894883173 cites W2766673373 @default.
• W2894883173 cites W2781525129 @default.
• W2894883173 cites W2802181901 @default.
• W2894883173 cites W2825739777 @default.
• W2894883173 cites W2885018676 @default.
• W2894883173 cites W749205244 @default.
• W2894883173 doi "https://doi.org/10.3390/ijms19103060" @default.
• W2894883173 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6213591" @default.
• W2894883173 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30301274" @default.
• W2894883173 hasPublicationYear "2018" @default.
• W2894883173 type Work @default.
• W2894883173 sameAs 2894883173 @default.
• W2894883173 citedByCount "18" @default.
• W2894883173 countsByYear W28948831732019 @default.
• W2894883173 countsByYear W28948831732020 @default.
• W2894883173 countsByYear W28948831732021 @default.
• W2894883173 countsByYear W28948831732022 @default.
• W2894883173 countsByYear W28948831732023 @default.
• W2894883173 crossrefType "journal-article" @default.
• W2894883173 hasAuthorship W2894883173A5001914805 @default.
• W2894883173 hasAuthorship W2894883173A5003856071 @default.
• W2894883173 hasAuthorship W2894883173A5019056174 @default.
• W2894883173 hasAuthorship W2894883173A5024471265 @default.
• W2894883173 hasAuthorship W2894883173A5033443384 @default.
• W2894883173 hasAuthorship W2894883173A5035358476 @default.
• W2894883173 hasAuthorship W2894883173A5063127682 @default.
• W2894883173 hasAuthorship W2894883173A5073515685 @default.
• W2894883173 hasAuthorship W2894883173A5074822731 @default.
• W2894883173 hasAuthorship W2894883173A5081957059 @default.
• W2894883173 hasBestOaLocation W28948831731 @default.
• W2894883173 hasConcept C126322002 @default.
• W2894883173 hasConcept C150903083 @default.
• W2894883173 hasConcept C153911025 @default.
• W2894883173 hasConcept C185592680 @default.
• W2894883173 hasConcept C190283241 @default.
• W2894883173 hasConcept C202751555 @default.
• W2894883173 hasConcept C207001950 @default.
• W2894883173 hasConcept C2776231280 @default.
• W2894883173 hasConcept C2776694085 @default.
• W2894883173 hasConcept C2778019345 @default.
• W2894883173 hasConcept C2778239845 @default.
• W2894883173 hasConcept C502942594 @default.
• W2894883173 hasConcept C553184892 @default.
• W2894883173 hasConcept C55493867 @default.
• W2894883173 hasConcept C62112901 @default.
• W2894883173 hasConcept C71924100 @default.

• next